Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.6570
+0.0484 (7.95%)
At close: Oct 20, 2025, 4:00 PM EDT
0.6551
-0.0019 (-0.29%)
After-hours: Oct 20, 2025, 7:58 PM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $2.85 million as of October 20, 2025. Its market cap has decreased by -64.49% in one year.
Market Cap
2.85M
Enterprise Value
-755.89K
1-Year Change
-64.49%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $2.85M, a decrease of -98.62%. That is a compound annual growth rate of -73.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 2.64M | -72.95% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |